nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—Zileuton—asthma	0.0273	0.0494	CbGbCtD
Bortezomib—CYP1A1—Isoprenaline—asthma	0.026	0.0471	CbGbCtD
Bortezomib—PTGS1—Zafirlukast—asthma	0.024	0.0435	CbGbCtD
Bortezomib—CYP1A1—Theophylline—asthma	0.0185	0.0336	CbGbCtD
Bortezomib—CYP2C8—Mometasone—asthma	0.0176	0.032	CbGbCtD
Bortezomib—CYP2C8—Salmeterol—asthma	0.0176	0.032	CbGbCtD
Bortezomib—PTGS1—Montelukast—asthma	0.0176	0.0318	CbGbCtD
Bortezomib—CYP2C8—Zafirlukast—asthma	0.0138	0.0251	CbGbCtD
Bortezomib—CYP1A2—Zileuton—asthma	0.0122	0.0221	CbGbCtD
Bortezomib—CYP2D6—Ciclesonide—asthma	0.0121	0.0219	CbGbCtD
Bortezomib—CYP2C19—Zafirlukast—asthma	0.0116	0.021	CbGbCtD
Bortezomib—CYP2C19—Arformoterol—asthma	0.0112	0.0203	CbGbCtD
Bortezomib—CYP2C19—Formoterol—asthma	0.0112	0.0203	CbGbCtD
Bortezomib—CYP2C9—Zileuton—asthma	0.011	0.0199	CbGbCtD
Bortezomib—CYP1A2—Zafirlukast—asthma	0.0107	0.0194	CbGbCtD
Bortezomib—CYP2C8—Theophylline—asthma	0.0107	0.0194	CbGbCtD
Bortezomib—CYP2C8—Montelukast—asthma	0.0101	0.0184	CbGbCtD
Bortezomib—CYP2C8—Loratadine—asthma	0.0101	0.0184	CbGbCtD
Bortezomib—CYP2D6—Ipratropium bromide—asthma	0.01	0.0182	CbGbCtD
Bortezomib—CYP2C9—Zafirlukast—asthma	0.00966	0.0175	CbGbCtD
Bortezomib—CYP3A4—Fluticasone furoate—asthma	0.00944	0.0171	CbGbCtD
Bortezomib—CYP2C9—Formoterol—asthma	0.00933	0.0169	CbGbCtD
Bortezomib—CYP2C9—Arformoterol—asthma	0.00933	0.0169	CbGbCtD
Bortezomib—CYP2D6—Zafirlukast—asthma	0.00883	0.016	CbGbCtD
Bortezomib—CYP1A2—Aminophylline—asthma	0.0088	0.0159	CbGbCtD
Bortezomib—CYP2D6—Arformoterol—asthma	0.00853	0.0154	CbGbCtD
Bortezomib—CYP2D6—Formoterol—asthma	0.00853	0.0154	CbGbCtD
Bortezomib—CYP2C19—Loratadine—asthma	0.0085	0.0154	CbGbCtD
Bortezomib—CYP3A4—Budesonide—asthma	0.00842	0.0152	CbGbCtD
Bortezomib—CYP1A2—Theophylline—asthma	0.00828	0.015	CbGbCtD
Bortezomib—CYP3A4—Indacaterol—asthma	0.0077	0.0139	CbGbCtD
Bortezomib—CYP3A4—Ciclesonide—asthma	0.0077	0.0139	CbGbCtD
Bortezomib—CYP2D6—Tiotropium—asthma	0.0076	0.0138	CbGbCtD
Bortezomib—CYP2C9—Theophylline—asthma	0.00746	0.0135	CbGbCtD
Bortezomib—CYP3A4—Salbutamol—asthma	0.00716	0.013	CbGbCtD
Bortezomib—CYP3A4—Flunisolide—asthma	0.00716	0.013	CbGbCtD
Bortezomib—CYP3A4—Salmeterol—asthma	0.00716	0.013	CbGbCtD
Bortezomib—CYP2C9—Montelukast—asthma	0.00707	0.0128	CbGbCtD
Bortezomib—CYP2C9—Loratadine—asthma	0.00707	0.0128	CbGbCtD
Bortezomib—CYP2D6—Theophylline—asthma	0.00682	0.0124	CbGbCtD
Bortezomib—CYP2D6—Loratadine—asthma	0.00647	0.0117	CbGbCtD
Bortezomib—CYP3A4—Zileuton—asthma	0.00638	0.0116	CbGbCtD
Bortezomib—CYP3A4—Ipratropium bromide—asthma	0.00638	0.0116	CbGbCtD
Bortezomib—CYP3A4—Fluticasone Propionate—asthma	0.00609	0.011	CbGbCtD
Bortezomib—CYP1A1—Dexamethasone—asthma	0.00608	0.011	CbGbCtD
Bortezomib—CYP2C8—Hydrocortisone—asthma	0.00564	0.0102	CbGbCtD
Bortezomib—CYP3A4—Zafirlukast—asthma	0.00562	0.0102	CbGbCtD
Bortezomib—CYP3A4—Tiotropium—asthma	0.00484	0.00876	CbGbCtD
Bortezomib—CYP2C19—Prednisone—asthma	0.00471	0.00853	CbGbCtD
Bortezomib—CYP3A4—Aminophylline—asthma	0.00461	0.00835	CbGbCtD
Bortezomib—CYP3A4—Theophylline—asthma	0.00434	0.00785	CbGbCtD
Bortezomib—CYP3A4—Loratadine—asthma	0.00411	0.00745	CbGbCtD
Bortezomib—CYP3A4—Montelukast—asthma	0.00411	0.00745	CbGbCtD
Bortezomib—CYP3A4—Methylprednisolone—asthma	0.00376	0.00681	CbGbCtD
Bortezomib—CYP2C8—Dexamethasone—asthma	0.00351	0.00635	CbGbCtD
Bortezomib—CYP2C19—Dexamethasone—asthma	0.00294	0.00533	CbGbCtD
Bortezomib—CYP3A4—Triamcinolone—asthma	0.00285	0.00516	CbGbCtD
Bortezomib—CTSG—respiratory system—asthma	0.0028	0.0325	CbGeAlD
Bortezomib—PSMA1—respiratory system—asthma	0.00268	0.0312	CbGeAlD
Bortezomib—CYP2C9—Dexamethasone—asthma	0.00245	0.00443	CbGbCtD
Bortezomib—CYP3A4—Betamethasone—asthma	0.00244	0.00443	CbGbCtD
Bortezomib—CYP3A4—Prednisolone—asthma	0.00241	0.00437	CbGbCtD
Bortezomib—CYP3A4—Hydrocortisone—asthma	0.00229	0.00414	CbGbCtD
Bortezomib—CYP3A4—Prednisone—asthma	0.00228	0.00413	CbGbCtD
Bortezomib—PSMA1—epithelium—asthma	0.00224	0.0261	CbGeAlD
Bortezomib—CYP2D6—Dexamethasone—asthma	0.00224	0.00405	CbGbCtD
Bortezomib—CTSG—cardiovascular system—asthma	0.00214	0.0249	CbGeAlD
Bortezomib—CTSG—trachea—asthma	0.00207	0.024	CbGeAlD
Bortezomib—PSMA1—cardiovascular system—asthma	0.00206	0.0239	CbGeAlD
Bortezomib—PSMD2—respiratory system—asthma	0.002	0.0232	CbGeAlD
Bortezomib—PSMD1—adrenal cortex—asthma	0.00189	0.022	CbGeAlD
Bortezomib—PSMD1—bronchus—asthma	0.00185	0.0216	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—asthma	0.00181	0.0211	CbGeAlD
Bortezomib—CTSG—adrenal gland—asthma	0.00169	0.0197	CbGeAlD
Bortezomib—PSMD2—adrenal cortex—asthma	0.00168	0.0195	CbGeAlD
Bortezomib—PSMD1—trachea—asthma	0.00167	0.0194	CbGeAlD
Bortezomib—PSMB8—adrenal cortex—asthma	0.00167	0.0194	CbGeAlD
Bortezomib—PSMD2—bronchus—asthma	0.00164	0.0191	CbGeAlD
Bortezomib—PSMB8—bronchus—asthma	0.00163	0.019	CbGeAlD
Bortezomib—PSMA1—adrenal gland—asthma	0.00163	0.0189	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—asthma	0.00161	0.0187	CbGeAlD
Bortezomib—PSMB1—respiratory system—asthma	0.00153	0.0178	CbGeAlD
Bortezomib—PSMD2—cardiovascular system—asthma	0.00153	0.0178	CbGeAlD
Bortezomib—PSMB2—respiratory system—asthma	0.00149	0.0174	CbGeAlD
Bortezomib—CTSG—lung—asthma	0.00148	0.0173	CbGeAlD
Bortezomib—PSMD2—trachea—asthma	0.00148	0.0172	CbGeAlD
Bortezomib—PSMB5—adrenal cortex—asthma	0.00147	0.0171	CbGeAlD
Bortezomib—PSMB8—trachea—asthma	0.00147	0.0171	CbGeAlD
Bortezomib—PSMB5—bronchus—asthma	0.00144	0.0168	CbGeAlD
Bortezomib—PSMA1—lung—asthma	0.00143	0.0166	CbGeAlD
Bortezomib—CYP3A4—Dexamethasone—asthma	0.00142	0.00258	CbGbCtD
Bortezomib—PSMB5—smooth muscle tissue—asthma	0.00141	0.0164	CbGeAlD
Bortezomib—PSMD1—adrenal gland—asthma	0.00137	0.0159	CbGeAlD
Bortezomib—PSMB5—trachea—asthma	0.0013	0.0151	CbGeAlD
Bortezomib—SLC31A1—respiratory system—asthma	0.00129	0.0151	CbGeAlD
Bortezomib—PSMB1—adrenal cortex—asthma	0.00129	0.015	CbGeAlD
Bortezomib—PSMB1—bronchus—asthma	0.00126	0.0147	CbGeAlD
Bortezomib—PSMB2—adrenal cortex—asthma	0.00125	0.0146	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—asthma	0.00123	0.0144	CbGeAlD
Bortezomib—PSMB2—bronchus—asthma	0.00123	0.0143	CbGeAlD
Bortezomib—PSMD2—adrenal gland—asthma	0.00121	0.0141	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—asthma	0.0012	0.014	CbGeAlD
Bortezomib—PSMB8—adrenal gland—asthma	0.0012	0.014	CbGeAlD
Bortezomib—PSMD1—lung—asthma	0.0012	0.0139	CbGeAlD
Bortezomib—PSMB1—cardiovascular system—asthma	0.00117	0.0136	CbGeAlD
Bortezomib—PSMB2—cardiovascular system—asthma	0.00114	0.0133	CbGeAlD
Bortezomib—PSMB1—trachea—asthma	0.00113	0.0132	CbGeAlD
Bortezomib—PSMB2—trachea—asthma	0.0011	0.0128	CbGeAlD
Bortezomib—SLC31A1—adrenal cortex—asthma	0.00109	0.0126	CbGeAlD
Bortezomib—SLC31A1—bronchus—asthma	0.00107	0.0124	CbGeAlD
Bortezomib—PSMB5—adrenal gland—asthma	0.00106	0.0124	CbGeAlD
Bortezomib—PSMD2—lung—asthma	0.00106	0.0123	CbGeAlD
Bortezomib—PSMB8—lung—asthma	0.00105	0.0123	CbGeAlD
Bortezomib—SLC31A1—trachea—asthma	0.000957	0.0111	CbGeAlD
Bortezomib—PSMB5—lung—asthma	0.000931	0.0108	CbGeAlD
Bortezomib—PSMB1—adrenal gland—asthma	0.000928	0.0108	CbGeAlD
Bortezomib—PSMB2—adrenal gland—asthma	0.000905	0.0105	CbGeAlD
Bortezomib—PSMB1—lung—asthma	0.000813	0.00946	CbGeAlD
Bortezomib—PSMB2—lung—asthma	0.000794	0.00923	CbGeAlD
Bortezomib—SLC31A1—adrenal gland—asthma	0.000784	0.00912	CbGeAlD
Bortezomib—SLC31A1—lung—asthma	0.000687	0.008	CbGeAlD
Bortezomib—CYP1A2—respiratory system—asthma	0.000446	0.00518	CbGeAlD
Bortezomib—CYP1A1—respiratory system—asthma	0.00044	0.00511	CbGeAlD
Bortezomib—PTGS1—respiratory system—asthma	0.000386	0.00449	CbGeAlD
Bortezomib—CYP1A1—epithelium—asthma	0.000367	0.00427	CbGeAlD
Bortezomib—CYP1A1—bronchus—asthma	0.000362	0.00421	CbGeAlD
Bortezomib—CYP1A1—trachea—asthma	0.000325	0.00378	CbGeAlD
Bortezomib—CYP2C9—cardiovascular system—asthma	0.000324	0.00377	CbGeAlD
Bortezomib—PTGS1—epithelium—asthma	0.000323	0.00375	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—asthma	0.000311	0.00362	CbGeAlD
Bortezomib—PTGS1—cardiovascular system—asthma	0.000296	0.00344	CbGeAlD
Bortezomib—PTGS1—trachea—asthma	0.000285	0.00332	CbGeAlD
Bortezomib—CYP1A2—lung—asthma	0.000237	0.00275	CbGeAlD
Bortezomib—PTGS1—adrenal gland—asthma	0.000234	0.00272	CbGeAlD
Bortezomib—CYP1A1—lung—asthma	0.000233	0.00272	CbGeAlD
Bortezomib—PTGS1—lung—asthma	0.000205	0.00239	CbGeAlD
Bortezomib—PSMD2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000187	0.0421	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Fluticasone furoate—asthma	0.000135	0.0303	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Beclomethasone—asthma	0.000128	0.0288	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Fluticasone Propionate—asthma	0.000126	0.0282	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Flunisolide—asthma	0.000121	0.0273	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Fluticasone furoate—asthma	0.000103	0.0231	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Mometasone—asthma	9.94e-05	0.0224	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Fluticasone Propionate—asthma	9.57e-05	0.0215	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Fluticasone furoate—asthma	9.48e-05	0.0213	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Fluticasone furoate—asthma	9.48e-05	0.0213	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Beclomethasone—asthma	9.23e-05	0.0208	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Budesonide—asthma	8.85e-05	0.0199	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Fluticasone Propionate—asthma	8.84e-05	0.0199	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Fluticasone Propionate—asthma	8.84e-05	0.0199	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Flunisolide—asthma	8.74e-05	0.0196	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Mometasone—asthma	7.16e-05	0.0161	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Beclomethasone—asthma	7.03e-05	0.0158	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Budesonide—asthma	6.74e-05	0.0152	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Flunisolide—asthma	6.65e-05	0.015	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Beclomethasone—asthma	6.5e-05	0.0146	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Beclomethasone—asthma	6.5e-05	0.0146	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Hydrocortisone—asthma	6.26e-05	0.0141	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Budesonide—asthma	6.23e-05	0.014	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Budesonide—asthma	6.23e-05	0.014	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Flunisolide—asthma	6.15e-05	0.0138	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Flunisolide—asthma	6.15e-05	0.0138	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Methylprednisolone—asthma	5.94e-05	0.0134	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Methylprednisolone—asthma	5.91e-05	0.0133	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Dexamethasone—asthma	5.84e-05	0.0131	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Betamethasone—asthma	5.84e-05	0.0131	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Triamcinolone—asthma	5.71e-05	0.0128	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Fluticasone furoate—asthma	5.5e-05	0.0124	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Fluticasone furoate—asthma	5.5e-05	0.0124	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Mometasone—asthma	5.45e-05	0.0123	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Prednisolone—asthma	5.26e-05	0.0118	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Fluticasone Propionate—asthma	5.13e-05	0.0115	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Fluticasone Propionate—asthma	5.13e-05	0.0115	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Mometasone—asthma	5.04e-05	0.0113	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Mometasone—asthma	5.04e-05	0.0113	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Hydrocortisone—asthma	4.53e-05	0.0102	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Methylprednisolone—asthma	4.28e-05	0.00961	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Betamethasone—asthma	4.21e-05	0.00946	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Dexamethasone—asthma	4.21e-05	0.00946	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Triamcinolone—asthma	4.11e-05	0.00924	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Prednisone—asthma	3.9e-05	0.00877	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Prednisolone—asthma	3.81e-05	0.00856	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Beclomethasone—asthma	3.77e-05	0.00848	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Beclomethasone—asthma	3.77e-05	0.00848	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Budesonide—asthma	3.62e-05	0.00813	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Budesonide—asthma	3.62e-05	0.00813	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Flunisolide—asthma	3.57e-05	0.00802	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Flunisolide—asthma	3.57e-05	0.00802	CbGdCrCtD
Bortezomib—PSMB8—Testosterone Propionate—Hydrocortisone—asthma	3.49e-05	0.00784	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Methylprednisolone—asthma	3.26e-05	0.00732	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Betamethasone—asthma	3.21e-05	0.00721	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Dexamethasone—asthma	3.21e-05	0.00721	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Hydrocortisone—asthma	3.19e-05	0.00717	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Hydrocortisone—asthma	3.19e-05	0.00717	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Triamcinolone—asthma	3.13e-05	0.00704	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Methylprednisolone—asthma	3.01e-05	0.00677	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Methylprednisolone—asthma	3.01e-05	0.00677	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Prednisone—asthma	2.97e-05	0.00668	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Dexamethasone—asthma	2.96e-05	0.00666	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Betamethasone—asthma	2.96e-05	0.00666	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Mometasone—asthma	2.92e-05	0.00657	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Mometasone—asthma	2.92e-05	0.00657	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Prednisolone—asthma	2.9e-05	0.00652	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Triamcinolone—asthma	2.89e-05	0.00651	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Triamcinolone—asthma	2.89e-05	0.00651	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Prednisone—asthma	2.75e-05	0.00618	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisone—asthma	2.75e-05	0.00618	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Prednisolone—asthma	2.68e-05	0.00603	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisolone—asthma	2.68e-05	0.00603	CbGdCrCtD
Bortezomib—PSMB8—Norethindrone—Hydrocortisone—asthma	2.61e-05	0.00587	CbGdCrCtD
Bortezomib—Oedema—Hydrocortisone—asthma	2.09e-05	9.05e-05	CcSEcCtD
Bortezomib—Convulsion—Triamcinolone—asthma	2.09e-05	9.05e-05	CcSEcCtD
Bortezomib—Tachycardia—Prednisolone—asthma	2.09e-05	9.05e-05	CcSEcCtD
Bortezomib—Convulsion—Methylprednisolone—asthma	2.08e-05	9.03e-05	CcSEcCtD
Bortezomib—Hypertension—Triamcinolone—asthma	2.08e-05	9.02e-05	CcSEcCtD
Bortezomib—PSMB8—Levonorgestrel—Hydrocortisone—asthma	2.08e-05	0.00467	CbGdCrCtD
Bortezomib—Hypertension—Methylprednisolone—asthma	2.08e-05	9e-05	CcSEcCtD
Bortezomib—Infection—Hydrocortisone—asthma	2.07e-05	8.99e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisolone—asthma	2.07e-05	8.96e-05	CcSEcCtD
Bortezomib—Shock—Hydrocortisone—asthma	2.05e-05	8.91e-05	CcSEcCtD
Bortezomib—Myalgia—Triamcinolone—asthma	2.05e-05	8.89e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Hydrocortisone—asthma	2.05e-05	8.88e-05	CcSEcCtD
Bortezomib—Arthralgia—Methylprednisolone—asthma	2.05e-05	8.87e-05	CcSEcCtD
Bortezomib—Myalgia—Methylprednisolone—asthma	2.05e-05	8.87e-05	CcSEcCtD
Bortezomib—Eye disorder—Prednisone—asthma	2.04e-05	8.86e-05	CcSEcCtD
Bortezomib—Anxiety—Methylprednisolone—asthma	2.04e-05	8.84e-05	CcSEcCtD
Bortezomib—Tachycardia—Hydrocortisone—asthma	2.04e-05	8.84e-05	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.03e-05	8.81e-05	CcSEcCtD
Bortezomib—Flushing—Prednisone—asthma	2.03e-05	8.8e-05	CcSEcCtD
Bortezomib—Skin disorder—Hydrocortisone—asthma	2.03e-05	8.79e-05	CcSEcCtD
Bortezomib—Ill-defined disorder—Betamethasone—asthma	2.03e-05	8.79e-05	CcSEcCtD
Bortezomib—Ill-defined disorder—Dexamethasone—asthma	2.03e-05	8.79e-05	CcSEcCtD
Bortezomib—Discomfort—Triamcinolone—asthma	2.03e-05	8.79e-05	CcSEcCtD
Bortezomib—Discomfort—Methylprednisolone—asthma	2.02e-05	8.77e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Hydrocortisone—asthma	2.02e-05	8.75e-05	CcSEcCtD
Bortezomib—Angioedema—Betamethasone—asthma	2e-05	8.66e-05	CcSEcCtD
Bortezomib—Angioedema—Dexamethasone—asthma	2e-05	8.66e-05	CcSEcCtD
Bortezomib—Anorexia—Hydrocortisone—asthma	1.99e-05	8.63e-05	CcSEcCtD
Bortezomib—Angiopathy—Prednisone—asthma	1.98e-05	8.6e-05	CcSEcCtD
Bortezomib—Confusional state—Methylprednisolone—asthma	1.98e-05	8.58e-05	CcSEcCtD
Bortezomib—Immune system disorder—Prednisone—asthma	1.97e-05	8.56e-05	CcSEcCtD
Bortezomib—Malaise—Dexamethasone—asthma	1.97e-05	8.55e-05	CcSEcCtD
Bortezomib—Malaise—Betamethasone—asthma	1.97e-05	8.55e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Triamcinolone—asthma	1.97e-05	8.52e-05	CcSEcCtD
Bortezomib—Oedema—Triamcinolone—asthma	1.97e-05	8.52e-05	CcSEcCtD
Bortezomib—Vertigo—Betamethasone—asthma	1.96e-05	8.51e-05	CcSEcCtD
Bortezomib—Vertigo—Dexamethasone—asthma	1.96e-05	8.51e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Methylprednisolone—asthma	1.96e-05	8.51e-05	CcSEcCtD
Bortezomib—Syncope—Dexamethasone—asthma	1.96e-05	8.5e-05	CcSEcCtD
Bortezomib—Syncope—Betamethasone—asthma	1.96e-05	8.5e-05	CcSEcCtD
Bortezomib—Arrhythmia—Prednisone—asthma	1.95e-05	8.47e-05	CcSEcCtD
Bortezomib—Infection—Triamcinolone—asthma	1.95e-05	8.47e-05	CcSEcCtD
Bortezomib—Hypotension—Hydrocortisone—asthma	1.95e-05	8.46e-05	CcSEcCtD
Bortezomib—Infection—Methylprednisolone—asthma	1.95e-05	8.45e-05	CcSEcCtD
Bortezomib—Shock—Triamcinolone—asthma	1.93e-05	8.39e-05	CcSEcCtD
Bortezomib—Insomnia—Prednisolone—asthma	1.93e-05	8.38e-05	CcSEcCtD
Bortezomib—Shock—Methylprednisolone—asthma	1.93e-05	8.37e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Methylprednisolone—asthma	1.92e-05	8.34e-05	CcSEcCtD
Bortezomib—Loss of consciousness—Dexamethasone—asthma	1.92e-05	8.33e-05	CcSEcCtD
Bortezomib—Loss of consciousness—Betamethasone—asthma	1.92e-05	8.33e-05	CcSEcCtD
Bortezomib—Paraesthesia—Prednisolone—asthma	1.92e-05	8.32e-05	CcSEcCtD
Bortezomib—Tachycardia—Triamcinolone—asthma	1.92e-05	8.32e-05	CcSEcCtD
Bortezomib—Mental disorder—Prednisone—asthma	1.92e-05	8.31e-05	CcSEcCtD
Bortezomib—Tachycardia—Methylprednisolone—asthma	1.91e-05	8.3e-05	CcSEcCtD
Bortezomib—Skin disorder—Methylprednisolone—asthma	1.91e-05	8.26e-05	CcSEcCtD
Bortezomib—Malnutrition—Prednisone—asthma	1.9e-05	8.25e-05	CcSEcCtD
Bortezomib—Erythema—Prednisone—asthma	1.9e-05	8.25e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Hydrocortisone—asthma	1.9e-05	8.25e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Triamcinolone—asthma	1.9e-05	8.24e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Methylprednisolone—asthma	1.9e-05	8.22e-05	CcSEcCtD
Bortezomib—Convulsion—Dexamethasone—asthma	1.89e-05	8.21e-05	CcSEcCtD
Bortezomib—Convulsion—Betamethasone—asthma	1.89e-05	8.21e-05	CcSEcCtD
Bortezomib—Insomnia—Hydrocortisone—asthma	1.89e-05	8.19e-05	CcSEcCtD
Bortezomib—Hypertension—Betamethasone—asthma	1.89e-05	8.18e-05	CcSEcCtD
Bortezomib—Hypertension—Dexamethasone—asthma	1.89e-05	8.18e-05	CcSEcCtD
Bortezomib—Paraesthesia—Hydrocortisone—asthma	1.87e-05	8.13e-05	CcSEcCtD
Bortezomib—Myalgia—Betamethasone—asthma	1.86e-05	8.07e-05	CcSEcCtD
Bortezomib—Myalgia—Dexamethasone—asthma	1.86e-05	8.07e-05	CcSEcCtD
Bortezomib—Anxiety—Dexamethasone—asthma	1.85e-05	8.04e-05	CcSEcCtD
Bortezomib—Anxiety—Betamethasone—asthma	1.85e-05	8.04e-05	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Hydrocortisone—asthma	1.85e-05	0.00416	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Hydrocortisone—asthma	1.85e-05	0.00416	CbGdCrCtD
Bortezomib—Discomfort—Betamethasone—asthma	1.84e-05	7.97e-05	CcSEcCtD
Bortezomib—Discomfort—Dexamethasone—asthma	1.84e-05	7.97e-05	CcSEcCtD
Bortezomib—Dyspepsia—Hydrocortisone—asthma	1.84e-05	7.97e-05	CcSEcCtD
Bortezomib—Hypotension—Methylprednisolone—asthma	1.83e-05	7.95e-05	CcSEcCtD
Bortezomib—Pain—Prednisolone—asthma	1.83e-05	7.93e-05	CcSEcCtD
Bortezomib—Decreased appetite—Hydrocortisone—asthma	1.81e-05	7.87e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Hydrocortisone—asthma	1.8e-05	7.82e-05	CcSEcCtD
Bortezomib—Fatigue—Hydrocortisone—asthma	1.8e-05	7.81e-05	CcSEcCtD
Bortezomib—Vision blurred—Prednisone—asthma	1.79e-05	7.78e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Triamcinolone—asthma	1.79e-05	7.77e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Methylprednisolone—asthma	1.79e-05	7.75e-05	CcSEcCtD
Bortezomib—Pain—Hydrocortisone—asthma	1.79e-05	7.74e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Betamethasone—asthma	1.78e-05	7.73e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Dexamethasone—asthma	1.78e-05	7.73e-05	CcSEcCtD
Bortezomib—Oedema—Betamethasone—asthma	1.78e-05	7.73e-05	CcSEcCtD
Bortezomib—Oedema—Dexamethasone—asthma	1.78e-05	7.73e-05	CcSEcCtD
Bortezomib—Insomnia—Triamcinolone—asthma	1.78e-05	7.71e-05	CcSEcCtD
Bortezomib—Insomnia—Methylprednisolone—asthma	1.77e-05	7.69e-05	CcSEcCtD
Bortezomib—Infection—Dexamethasone—asthma	1.77e-05	7.68e-05	CcSEcCtD
Bortezomib—Infection—Betamethasone—asthma	1.77e-05	7.68e-05	CcSEcCtD
Bortezomib—Ill-defined disorder—Prednisone—asthma	1.77e-05	7.66e-05	CcSEcCtD
Bortezomib—Paraesthesia—Triamcinolone—asthma	1.77e-05	7.65e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisolone—asthma	1.76e-05	7.64e-05	CcSEcCtD
Bortezomib—Paraesthesia—Methylprednisolone—asthma	1.76e-05	7.64e-05	CcSEcCtD
Bortezomib—Anaemia—Prednisone—asthma	1.76e-05	7.63e-05	CcSEcCtD
Bortezomib—Shock—Dexamethasone—asthma	1.75e-05	7.61e-05	CcSEcCtD
Bortezomib—Shock—Betamethasone—asthma	1.75e-05	7.61e-05	CcSEcCtD
Bortezomib—Dyspnoea—Triamcinolone—asthma	1.75e-05	7.6e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Dexamethasone—asthma	1.75e-05	7.59e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Betamethasone—asthma	1.75e-05	7.59e-05	CcSEcCtD
Bortezomib—Agitation—Prednisone—asthma	1.75e-05	7.58e-05	CcSEcCtD
Bortezomib—Thrombocytopenia—Betamethasone—asthma	1.75e-05	7.57e-05	CcSEcCtD
Bortezomib—Thrombocytopenia—Dexamethasone—asthma	1.75e-05	7.57e-05	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Methylprednisolone—asthma	1.75e-05	0.00393	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Methylprednisolone—asthma	1.75e-05	0.00393	CbGdCrCtD
Bortezomib—Tachycardia—Dexamethasone—asthma	1.74e-05	7.55e-05	CcSEcCtD
Bortezomib—Tachycardia—Betamethasone—asthma	1.74e-05	7.55e-05	CcSEcCtD
Bortezomib—Angioedema—Prednisone—asthma	1.74e-05	7.54e-05	CcSEcCtD
Bortezomib—Dyspepsia—Triamcinolone—asthma	1.73e-05	7.5e-05	CcSEcCtD
Bortezomib—Dyspepsia—Methylprednisolone—asthma	1.73e-05	7.49e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Betamethasone—asthma	1.72e-05	7.48e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Dexamethasone—asthma	1.72e-05	7.48e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Hydrocortisone—asthma	1.72e-05	7.46e-05	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Dexamethasone—asthma	1.72e-05	0.00386	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Betamethasone—asthma	1.72e-05	0.00386	CbGdCrCtD
Bortezomib—Malaise—Prednisone—asthma	1.72e-05	7.44e-05	CcSEcCtD
Bortezomib—Vertigo—Prednisone—asthma	1.71e-05	7.42e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Hydrocortisone—asthma	1.71e-05	7.4e-05	CcSEcCtD
Bortezomib—Syncope—Prednisone—asthma	1.71e-05	7.4e-05	CcSEcCtD
Bortezomib—Anorexia—Dexamethasone—asthma	1.7e-05	7.37e-05	CcSEcCtD
Bortezomib—Anorexia—Betamethasone—asthma	1.7e-05	7.37e-05	CcSEcCtD
Bortezomib—Urticaria—Prednisolone—asthma	1.7e-05	7.36e-05	CcSEcCtD
Bortezomib—Fatigue—Triamcinolone—asthma	1.69e-05	7.35e-05	CcSEcCtD
Bortezomib—Fatigue—Methylprednisolone—asthma	1.69e-05	7.33e-05	CcSEcCtD
Bortezomib—Pain—Triamcinolone—asthma	1.68e-05	7.29e-05	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Triamcinolone—asthma	1.68e-05	0.00378	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Triamcinolone—asthma	1.68e-05	0.00378	CbGdCrCtD
Bortezomib—Loss of consciousness—Prednisone—asthma	1.67e-05	7.25e-05	CcSEcCtD
Bortezomib—Hypotension—Dexamethasone—asthma	1.67e-05	7.23e-05	CcSEcCtD
Bortezomib—Hypotension—Betamethasone—asthma	1.67e-05	7.23e-05	CcSEcCtD
Bortezomib—Urticaria—Hydrocortisone—asthma	1.66e-05	7.19e-05	CcSEcCtD
Bortezomib—Abdominal pain—Hydrocortisone—asthma	1.65e-05	7.16e-05	CcSEcCtD
Bortezomib—Body temperature increased—Hydrocortisone—asthma	1.65e-05	7.16e-05	CcSEcCtD
Bortezomib—Convulsion—Prednisone—asthma	1.65e-05	7.15e-05	CcSEcCtD
Bortezomib—Hypertension—Prednisone—asthma	1.64e-05	7.13e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Dexamethasone—asthma	1.63e-05	7.05e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Betamethasone—asthma	1.63e-05	7.05e-05	CcSEcCtD
Bortezomib—Arthralgia—Prednisone—asthma	1.62e-05	7.03e-05	CcSEcCtD
Bortezomib—Myalgia—Prednisone—asthma	1.62e-05	7.03e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Triamcinolone—asthma	1.62e-05	7.02e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Methylprednisolone—asthma	1.62e-05	7.01e-05	CcSEcCtD
Bortezomib—Anxiety—Prednisone—asthma	1.61e-05	7e-05	CcSEcCtD
Bortezomib—Insomnia—Betamethasone—asthma	1.61e-05	7e-05	CcSEcCtD
Bortezomib—Insomnia—Dexamethasone—asthma	1.61e-05	7e-05	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.61e-05	6.98e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Methylprednisolone—asthma	1.6e-05	6.95e-05	CcSEcCtD
Bortezomib—Paraesthesia—Dexamethasone—asthma	1.6e-05	6.95e-05	CcSEcCtD
Bortezomib—Paraesthesia—Betamethasone—asthma	1.6e-05	6.95e-05	CcSEcCtD
Bortezomib—Discomfort—Prednisone—asthma	1.6e-05	6.94e-05	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisone—asthma	1.59e-05	0.00358	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisone—asthma	1.59e-05	0.00358	CbGdCrCtD
Bortezomib—Hypersensitivity—Prednisolone—asthma	1.58e-05	6.83e-05	CcSEcCtD
Bortezomib—Dyspepsia—Betamethasone—asthma	1.57e-05	6.81e-05	CcSEcCtD
Bortezomib—Dyspepsia—Dexamethasone—asthma	1.57e-05	6.81e-05	CcSEcCtD
Bortezomib—Urticaria—Triamcinolone—asthma	1.56e-05	6.77e-05	CcSEcCtD
Bortezomib—Urticaria—Methylprednisolone—asthma	1.56e-05	6.76e-05	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisolone—asthma	1.56e-05	0.0035	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisolone—asthma	1.56e-05	0.0035	CbGdCrCtD
Bortezomib—Body temperature increased—Triamcinolone—asthma	1.55e-05	6.74e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Prednisone—asthma	1.55e-05	6.74e-05	CcSEcCtD
Bortezomib—Oedema—Prednisone—asthma	1.55e-05	6.74e-05	CcSEcCtD
Bortezomib—Abdominal pain—Methylprednisolone—asthma	1.55e-05	6.72e-05	CcSEcCtD
Bortezomib—Decreased appetite—Betamethasone—asthma	1.55e-05	6.72e-05	CcSEcCtD
Bortezomib—Decreased appetite—Dexamethasone—asthma	1.55e-05	6.72e-05	CcSEcCtD
Bortezomib—Infection—Prednisone—asthma	1.54e-05	6.69e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Dexamethasone—asthma	1.54e-05	6.68e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Betamethasone—asthma	1.54e-05	6.68e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Hydrocortisone—asthma	1.54e-05	6.67e-05	CcSEcCtD
Bortezomib—Fatigue—Dexamethasone—asthma	1.54e-05	6.67e-05	CcSEcCtD
Bortezomib—Fatigue—Betamethasone—asthma	1.54e-05	6.67e-05	CcSEcCtD
Bortezomib—Shock—Prednisone—asthma	1.53e-05	6.63e-05	CcSEcCtD
Bortezomib—Pain—Dexamethasone—asthma	1.53e-05	6.61e-05	CcSEcCtD
Bortezomib—Pain—Betamethasone—asthma	1.53e-05	6.61e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Prednisone—asthma	1.52e-05	6.61e-05	CcSEcCtD
Bortezomib—Tachycardia—Prednisone—asthma	1.52e-05	6.57e-05	CcSEcCtD
Bortezomib—Skin disorder—Prednisone—asthma	1.51e-05	6.54e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisone—asthma	1.5e-05	6.51e-05	CcSEcCtD
Bortezomib—Asthenia—Hydrocortisone—asthma	1.5e-05	6.5e-05	CcSEcCtD
Bortezomib—Anorexia—Prednisone—asthma	1.48e-05	6.42e-05	CcSEcCtD
Bortezomib—Pruritus—Hydrocortisone—asthma	1.48e-05	6.4e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Betamethasone—asthma	1.47e-05	6.37e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Dexamethasone—asthma	1.47e-05	6.37e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Dexamethasone—asthma	1.46e-05	6.32e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Betamethasone—asthma	1.46e-05	6.32e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Triamcinolone—asthma	1.45e-05	6.28e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Methylprednisolone—asthma	1.45e-05	6.27e-05	CcSEcCtD
Bortezomib—Diarrhoea—Hydrocortisone—asthma	1.43e-05	6.19e-05	CcSEcCtD
Bortezomib—Urticaria—Dexamethasone—asthma	1.42e-05	6.14e-05	CcSEcCtD
Bortezomib—Urticaria—Betamethasone—asthma	1.42e-05	6.14e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Prednisone—asthma	1.42e-05	6.14e-05	CcSEcCtD
Bortezomib—Dizziness—Prednisolone—asthma	1.41e-05	6.13e-05	CcSEcCtD
Bortezomib—Asthenia—Triamcinolone—asthma	1.41e-05	6.12e-05	CcSEcCtD
Bortezomib—Body temperature increased—Dexamethasone—asthma	1.41e-05	6.11e-05	CcSEcCtD
Bortezomib—Abdominal pain—Dexamethasone—asthma	1.41e-05	6.11e-05	CcSEcCtD
Bortezomib—Abdominal pain—Betamethasone—asthma	1.41e-05	6.11e-05	CcSEcCtD
Bortezomib—Body temperature increased—Betamethasone—asthma	1.41e-05	6.11e-05	CcSEcCtD
Bortezomib—Asthenia—Methylprednisolone—asthma	1.41e-05	6.1e-05	CcSEcCtD
Bortezomib—Insomnia—Prednisone—asthma	1.41e-05	6.09e-05	CcSEcCtD
Bortezomib—Paraesthesia—Prednisone—asthma	1.39e-05	6.05e-05	CcSEcCtD
Bortezomib—Pruritus—Triamcinolone—asthma	1.39e-05	6.03e-05	CcSEcCtD
Bortezomib—Pruritus—Methylprednisolone—asthma	1.39e-05	6.02e-05	CcSEcCtD
Bortezomib—Dizziness—Hydrocortisone—asthma	1.38e-05	5.99e-05	CcSEcCtD
Bortezomib—Dyspepsia—Prednisone—asthma	1.37e-05	5.93e-05	CcSEcCtD
Bortezomib—Decreased appetite—Prednisone—asthma	1.35e-05	5.86e-05	CcSEcCtD
Bortezomib—Rash—Prednisolone—asthma	1.35e-05	5.84e-05	CcSEcCtD
Bortezomib—Dermatitis—Prednisolone—asthma	1.35e-05	5.84e-05	CcSEcCtD
Bortezomib—Diarrhoea—Methylprednisolone—asthma	1.34e-05	5.82e-05	CcSEcCtD
Bortezomib—Fatigue—Prednisone—asthma	1.34e-05	5.81e-05	CcSEcCtD
Bortezomib—Headache—Prednisolone—asthma	1.34e-05	5.81e-05	CcSEcCtD
Bortezomib—Constipation—Prednisone—asthma	1.33e-05	5.76e-05	CcSEcCtD
Bortezomib—Vomiting—Hydrocortisone—asthma	1.33e-05	5.76e-05	CcSEcCtD
Bortezomib—Rash—Hydrocortisone—asthma	1.32e-05	5.71e-05	CcSEcCtD
Bortezomib—Dermatitis—Hydrocortisone—asthma	1.32e-05	5.7e-05	CcSEcCtD
Bortezomib—Headache—Hydrocortisone—asthma	1.31e-05	5.67e-05	CcSEcCtD
Bortezomib—Dizziness—Triamcinolone—asthma	1.3e-05	5.64e-05	CcSEcCtD
Bortezomib—Dizziness—Methylprednisolone—asthma	1.3e-05	5.62e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisone—asthma	1.28e-05	5.55e-05	CcSEcCtD
Bortezomib—Asthenia—Betamethasone—asthma	1.28e-05	5.55e-05	CcSEcCtD
Bortezomib—Asthenia—Dexamethasone—asthma	1.28e-05	5.55e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Prednisone—asthma	1.27e-05	5.51e-05	CcSEcCtD
Bortezomib—Nausea—Prednisolone—asthma	1.27e-05	5.51e-05	CcSEcCtD
Bortezomib—Pruritus—Betamethasone—asthma	1.26e-05	5.47e-05	CcSEcCtD
Bortezomib—Pruritus—Dexamethasone—asthma	1.26e-05	5.47e-05	CcSEcCtD
Bortezomib—Vomiting—Triamcinolone—asthma	1.25e-05	5.42e-05	CcSEcCtD
Bortezomib—Vomiting—Methylprednisolone—asthma	1.25e-05	5.41e-05	CcSEcCtD
Bortezomib—Nausea—Hydrocortisone—asthma	1.24e-05	5.38e-05	CcSEcCtD
Bortezomib—Rash—Triamcinolone—asthma	1.24e-05	5.37e-05	CcSEcCtD
Bortezomib—Dermatitis—Triamcinolone—asthma	1.24e-05	5.37e-05	CcSEcCtD
Bortezomib—Rash—Methylprednisolone—asthma	1.24e-05	5.36e-05	CcSEcCtD
Bortezomib—Dermatitis—Methylprednisolone—asthma	1.24e-05	5.36e-05	CcSEcCtD
Bortezomib—Urticaria—Prednisone—asthma	1.23e-05	5.35e-05	CcSEcCtD
Bortezomib—Headache—Triamcinolone—asthma	1.23e-05	5.34e-05	CcSEcCtD
Bortezomib—Headache—Methylprednisolone—asthma	1.23e-05	5.33e-05	CcSEcCtD
Bortezomib—Body temperature increased—Prednisone—asthma	1.23e-05	5.32e-05	CcSEcCtD
Bortezomib—Abdominal pain—Prednisone—asthma	1.23e-05	5.32e-05	CcSEcCtD
Bortezomib—Diarrhoea—Dexamethasone—asthma	1.22e-05	5.29e-05	CcSEcCtD
Bortezomib—Diarrhoea—Betamethasone—asthma	1.22e-05	5.29e-05	CcSEcCtD
Bortezomib—Dizziness—Dexamethasone—asthma	1.18e-05	5.11e-05	CcSEcCtD
Bortezomib—Dizziness—Betamethasone—asthma	1.18e-05	5.11e-05	CcSEcCtD
Bortezomib—Nausea—Triamcinolone—asthma	1.17e-05	5.06e-05	CcSEcCtD
Bortezomib—Nausea—Methylprednisolone—asthma	1.17e-05	5.05e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Prednisone—asthma	1.14e-05	4.96e-05	CcSEcCtD
Bortezomib—Vomiting—Dexamethasone—asthma	1.13e-05	4.92e-05	CcSEcCtD
Bortezomib—Vomiting—Betamethasone—asthma	1.13e-05	4.92e-05	CcSEcCtD
Bortezomib—Rash—Betamethasone—asthma	1.12e-05	4.88e-05	CcSEcCtD
Bortezomib—Rash—Dexamethasone—asthma	1.12e-05	4.88e-05	CcSEcCtD
Bortezomib—Dermatitis—Dexamethasone—asthma	1.12e-05	4.87e-05	CcSEcCtD
Bortezomib—Dermatitis—Betamethasone—asthma	1.12e-05	4.87e-05	CcSEcCtD
Bortezomib—Headache—Dexamethasone—asthma	1.12e-05	4.85e-05	CcSEcCtD
Bortezomib—Headache—Betamethasone—asthma	1.12e-05	4.85e-05	CcSEcCtD
Bortezomib—Asthenia—Prednisone—asthma	1.11e-05	4.83e-05	CcSEcCtD
Bortezomib—Pruritus—Prednisone—asthma	1.1e-05	4.77e-05	CcSEcCtD
Bortezomib—Diarrhoea—Prednisone—asthma	1.06e-05	4.61e-05	CcSEcCtD
Bortezomib—Nausea—Betamethasone—asthma	1.06e-05	4.59e-05	CcSEcCtD
Bortezomib—Nausea—Dexamethasone—asthma	1.06e-05	4.59e-05	CcSEcCtD
Bortezomib—Dizziness—Prednisone—asthma	1.03e-05	4.45e-05	CcSEcCtD
Bortezomib—Vomiting—Prednisone—asthma	9.88e-06	4.28e-05	CcSEcCtD
Bortezomib—Rash—Prednisone—asthma	9.79e-06	4.25e-05	CcSEcCtD
Bortezomib—Dermatitis—Prednisone—asthma	9.79e-06	4.24e-05	CcSEcCtD
Bortezomib—Headache—Prednisone—asthma	9.73e-06	4.22e-05	CcSEcCtD
Bortezomib—Nausea—Prednisone—asthma	9.23e-06	4e-05	CcSEcCtD
Bortezomib—CYP2C8—Metabolism—GSTT1—asthma	5.18e-06	4.09e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	5.16e-06	4.07e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—STAT3—asthma	5.13e-06	4.05e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—STAT3—asthma	5.13e-06	4.05e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—STAT3—asthma	5.13e-06	4.05e-05	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—asthma	5.12e-06	4.04e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PLA2G4A—asthma	5.11e-06	4.03e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GSTM1—asthma	5.11e-06	4.03e-05	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—asthma	5.1e-06	4.02e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RHOA—asthma	5.09e-06	4.02e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RHOA—asthma	5.09e-06	4.02e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RHOA—asthma	5.09e-06	4.02e-05	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—asthma	5.08e-06	4e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CARM1—asthma	5.07e-06	4e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—STAT3—asthma	5.06e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—EGFR—asthma	5.05e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—EGFR—asthma	5.05e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—EGFR—asthma	5.05e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NOS3—asthma	5.04e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NOS3—asthma	5.04e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NOS3—asthma	5.04e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RHOA—asthma	5.02e-06	3.96e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DCN—asthma	5e-06	3.94e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—EGFR—asthma	4.98e-06	3.93e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NOS3—asthma	4.97e-06	3.92e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALOX5—asthma	4.89e-06	3.86e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALOX5AP—asthma	4.87e-06	3.84e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALOX15—asthma	4.87e-06	3.84e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALDH2—asthma	4.86e-06	3.84e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALOX5—asthma	4.85e-06	3.82e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTEN—asthma	4.81e-06	3.79e-05	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTEN—asthma	4.81e-06	3.79e-05	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTEN—asthma	4.81e-06	3.79e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—VEGFA—asthma	4.79e-06	3.78e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	4.78e-06	3.77e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—VEGFA—asthma	4.77e-06	3.76e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFB1—asthma	4.76e-06	3.75e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFB1—asthma	4.76e-06	3.75e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFB1—asthma	4.76e-06	3.75e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—VEGFA—asthma	4.74e-06	3.74e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—STAT3—asthma	4.74e-06	3.74e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTEN—asthma	4.74e-06	3.74e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALDH7A1—asthma	4.73e-06	3.73e-05	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—asthma	4.73e-06	3.73e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—STAT3—asthma	4.72e-06	3.72e-05	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—asthma	4.71e-06	3.71e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PPP2CA—asthma	4.71e-06	3.71e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NQO1—asthma	4.7e-06	3.71e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—STAT3—asthma	4.7e-06	3.71e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFB1—asthma	4.69e-06	3.7e-05	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—asthma	4.69e-06	3.7e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	4.68e-06	3.69e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CARM1—asthma	4.67e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—EGFR—asthma	4.67e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—EGFR—asthma	4.67e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—EGFR—asthma	4.67e-06	3.68e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CHAT—asthma	4.65e-06	3.67e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTT1—asthma	4.63e-06	3.65e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CARM1—asthma	4.63e-06	3.65e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—EGFR—asthma	4.6e-06	3.63e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DCN—asthma	4.6e-06	3.63e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ADCY2—asthma	4.6e-06	3.63e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DCN—asthma	4.56e-06	3.6e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.56e-06	3.6e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ARG2—asthma	4.54e-06	3.58e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALDH2—asthma	4.47e-06	3.53e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL8—asthma	4.47e-06	3.53e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL8—asthma	4.47e-06	3.53e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL8—asthma	4.47e-06	3.53e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALDH2—asthma	4.43e-06	3.5e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL8—asthma	4.41e-06	3.48e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFB1—asthma	4.4e-06	3.47e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFB1—asthma	4.38e-06	3.45e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFB1—asthma	4.35e-06	3.43e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—EGFR—asthma	4.31e-06	3.4e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NQO1—asthma	4.31e-06	3.4e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—EGFR—asthma	4.29e-06	3.38e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL2—asthma	4.27e-06	3.37e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL2—asthma	4.27e-06	3.37e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL2—asthma	4.27e-06	3.37e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—EGFR—asthma	4.27e-06	3.37e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	4.26e-06	3.36e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	4.26e-06	3.36e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTT1—asthma	4.26e-06	3.36e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTT1—asthma	4.22e-06	3.33e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ADCY2—asthma	4.22e-06	3.32e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL2—asthma	4.21e-06	3.32e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.18e-06	3.3e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALOX5—asthma	4.14e-06	3.27e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—asthma	4.04e-06	3.19e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—asthma	4.04e-06	3.19e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—asthma	4.04e-06	3.19e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PTEN—asthma	4.02e-06	3.17e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PTEN—asthma	4.02e-06	3.17e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PTEN—asthma	4.02e-06	3.17e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—asthma	3.99e-06	3.14e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—asthma	3.98e-06	3.14e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PTEN—asthma	3.96e-06	3.13e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CARM1—asthma	3.95e-06	3.12e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GSTP1—asthma	3.92e-06	3.09e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DCN—asthma	3.9e-06	3.07e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	3.89e-06	3.07e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—asthma	3.88e-06	3.06e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—asthma	3.88e-06	3.06e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—asthma	3.88e-06	3.06e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—HMOX1—asthma	3.86e-06	3.05e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ITPR1—asthma	3.86e-06	3.04e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NQO1—asthma	3.84e-06	3.03e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—asthma	3.83e-06	3.02e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAT—asthma	3.81e-06	3.01e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALDH2—asthma	3.79e-06	2.99e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ADCY2—asthma	3.76e-06	2.97e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALOX15—asthma	3.76e-06	2.97e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALOX5AP—asthma	3.76e-06	2.97e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.73e-06	2.94e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	3.64e-06	2.87e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	3.64e-06	2.87e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—VEGFA—asthma	3.63e-06	2.86e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—VEGFA—asthma	3.63e-06	2.86e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—VEGFA—asthma	3.63e-06	2.86e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—asthma	3.61e-06	2.85e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTT1—asthma	3.6e-06	2.84e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PLA2G4A—asthma	3.6e-06	2.84e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GSTM1—asthma	3.6e-06	2.84e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—STAT3—asthma	3.59e-06	2.84e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—STAT3—asthma	3.59e-06	2.84e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—STAT3—asthma	3.59e-06	2.84e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GSTP1—asthma	3.59e-06	2.83e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CHAT—asthma	3.59e-06	2.83e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—asthma	3.59e-06	2.83e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—asthma	3.59e-06	2.83e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—asthma	3.59e-06	2.83e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—VEGFA—asthma	3.58e-06	2.82e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—STAT3—asthma	3.54e-06	2.8e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—HMOX1—asthma	3.54e-06	2.79e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NQO1—asthma	3.54e-06	2.79e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ITPR1—asthma	3.54e-06	2.79e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—asthma	3.53e-06	2.79e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NQO1—asthma	3.51e-06	2.77e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAT—asthma	3.5e-06	2.76e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ADCY2—asthma	3.46e-06	2.73e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ADCY2—asthma	3.43e-06	2.71e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.4e-06	2.68e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFB1—asthma	3.33e-06	2.63e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFB1—asthma	3.33e-06	2.63e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFB1—asthma	3.33e-06	2.63e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	3.32e-06	2.62e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPP2CA—asthma	3.32e-06	2.62e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—asthma	3.31e-06	2.61e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GSTM1—asthma	3.3e-06	2.6e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PLA2G4A—asthma	3.3e-06	2.6e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—asthma	3.3e-06	2.6e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ALB—asthma	3.29e-06	2.6e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFB1—asthma	3.28e-06	2.59e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—asthma	3.28e-06	2.59e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—EGFR—asthma	3.27e-06	2.58e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—EGFR—asthma	3.27e-06	2.58e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—EGFR—asthma	3.27e-06	2.58e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	3.25e-06	2.57e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—EGFR—asthma	3.22e-06	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTP1—asthma	3.21e-06	2.53e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALOX5—asthma	3.2e-06	2.52e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HMOX1—asthma	3.16e-06	2.49e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ITPR1—asthma	3.16e-06	2.49e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—asthma	3.15e-06	2.48e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAT—asthma	3.12e-06	2.46e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CARM1—asthma	3.05e-06	2.41e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPP2CA—asthma	3.04e-06	2.4e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DCN—asthma	3.01e-06	2.37e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NQO1—asthma	3e-06	2.36e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	2.97e-06	2.34e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTP1—asthma	2.95e-06	2.33e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTM1—asthma	2.95e-06	2.32e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PLA2G4A—asthma	2.95e-06	2.32e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADCY2—asthma	2.93e-06	2.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALDH2—asthma	2.92e-06	2.31e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTP1—asthma	2.92e-06	2.31e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HMOX1—asthma	2.91e-06	2.29e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.91e-06	2.29e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ITPR1—asthma	2.9e-06	2.29e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HMOX1—asthma	2.88e-06	2.27e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—asthma	2.88e-06	2.27e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ITPR1—asthma	2.88e-06	2.27e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAT—asthma	2.87e-06	2.26e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAT—asthma	2.85e-06	2.24e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTT1—asthma	2.78e-06	2.19e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPP2CA—asthma	2.71e-06	2.14e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTM1—asthma	2.71e-06	2.14e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PLA2G4A—asthma	2.71e-06	2.14e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PLA2G4A—asthma	2.69e-06	2.12e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTM1—asthma	2.69e-06	2.12e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—asthma	2.55e-06	2.01e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	2.53e-06	2e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTEN—asthma	2.51e-06	1.98e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—asthma	2.51e-06	1.98e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—asthma	2.51e-06	1.98e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—asthma	2.51e-06	1.98e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTP1—asthma	2.5e-06	1.97e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPP2CA—asthma	2.5e-06	1.97e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—asthma	2.48e-06	1.95e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPP2CA—asthma	2.47e-06	1.95e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HMOX1—asthma	2.46e-06	1.94e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ITPR1—asthma	2.46e-06	1.94e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAT—asthma	2.43e-06	1.92e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—asthma	2.33e-06	1.84e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—asthma	2.32e-06	1.83e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NQO1—asthma	2.31e-06	1.82e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PLA2G4A—asthma	2.3e-06	1.81e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTM1—asthma	2.3e-06	1.81e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADCY2—asthma	2.26e-06	1.78e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—asthma	2.22e-06	1.75e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—asthma	2.13e-06	1.68e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPP2CA—asthma	2.11e-06	1.67e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—asthma	2.08e-06	1.64e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—asthma	2.03e-06	1.61e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—asthma	2.03e-06	1.6e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTP1—asthma	1.93e-06	1.52e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—asthma	1.92e-06	1.51e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HMOX1—asthma	1.9e-06	1.5e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—asthma	1.9e-06	1.5e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—asthma	1.9e-06	1.5e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ITPR1—asthma	1.9e-06	1.5e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAT—asthma	1.88e-06	1.48e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—asthma	1.86e-06	1.47e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—asthma	1.82e-06	1.43e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PLA2G4A—asthma	1.77e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTM1—asthma	1.77e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTEN—asthma	1.77e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—asthma	1.75e-06	1.38e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—asthma	1.73e-06	1.37e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—asthma	1.67e-06	1.32e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—asthma	1.66e-06	1.31e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—asthma	1.66e-06	1.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPP2CA—asthma	1.63e-06	1.29e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTEN—asthma	1.62e-06	1.28e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—asthma	1.62e-06	1.28e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—asthma	1.53e-06	1.21e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—asthma	1.51e-06	1.19e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—asthma	1.48e-06	1.17e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTEN—asthma	1.45e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—asthma	1.42e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTEN—asthma	1.33e-06	1.05e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTEN—asthma	1.32e-06	1.04e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—asthma	1.29e-06	1.02e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—asthma	1.25e-06	9.88e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—asthma	1.14e-06	9.01e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTEN—asthma	1.13e-06	8.9e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—asthma	1.09e-06	8.62e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—asthma	9.99e-07	7.88e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTEN—asthma	8.71e-07	6.87e-06	CbGpPWpGaD
